DexCom, Inc. vs Hyatt Hotels Corporation — how do they compare? DexCom, Inc. trades at $89.2 (market cap $33.79B), while Hyatt Hotels Corporation trades at $172.22 (market cap $16.27B). The key difference: DexCom, Inc. is far larger — about 2.1× Hyatt Hotels Corporation's market cap, and Hyatt Hotels Corporation pays a 0.35% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| DXCM | H | |
|---|---|---|
Market Cap | $33.79B | $16.27B |
Sector | Health | Consumer Cyclical |
52-Week High | $89.53 | $202.09 |
52-Week Low | $54.84 | $135.42 |
Enterprise Value | $33.24B | $20.17B |
Dividend Yield | — | 0.35% |
Trailing returns across standard periods
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →Hyatt is an operator of 1,162 owned (5% of total rooms) and managed and franchise (95%) properties across roughly 20 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, and the wellness brand Miraval. Hyatt acquired Two Roads in November 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 66% Americas, 18% Asia-Pacific, and 16% rest of world.
Read more on H →